AUD 0.02
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 4.03 Million NZD | 16.14% |
2023 | 3.47 Million NZD | -20.9% |
2022 | 4.38 Million NZD | -63.46% |
2021 | 12 Million NZD | 48.68% |
2020 | 8.07 Million NZD | -35.64% |
2019 | 12.54 Million NZD | 3.11% |
2018 | 12.16 Million NZD | -19.11% |
2017 | 15.04 Million NZD | 3.19% |
2016 | 14.57 Million NZD | 36.93% |
2015 | 10.64 Million NZD | -7.44% |
2014 | 11.5 Million NZD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 FY | 4.03 Million NZD | 16.14% |
2024 Q4 | 4.03 Million NZD | 0.0% |
2024 Q1 | 2.08 Million NZD | -39.9% |
2024 Q2 | 2.08 Million NZD | 0.0% |
2024 Q3 | 4.03 Million NZD | 93.26% |
2023 Q4 | 3.47 Million NZD | 0.0% |
2023 Q3 | 3.47 Million NZD | 18.32% |
2023 Q2 | 2.93 Million NZD | 0.0% |
2023 Q1 | 2.93 Million NZD | -33.15% |
2023 FY | 3.47 Million NZD | -20.9% |
2022 Q4 | 4.38 Million NZD | 0.0% |
2022 Q2 | 10.34 Million NZD | 0.0% |
2022 FY | 4.38 Million NZD | -63.46% |
2022 Q1 | 10.34 Million NZD | -13.86% |
2022 Q3 | 4.38 Million NZD | -57.58% |
2021 Q3 | 12 Million NZD | -1.37% |
2021 Q4 | 12 Million NZD | 0.0% |
2021 FY | 12 Million NZD | 48.68% |
2021 Q1 | 12.17 Million NZD | 50.75% |
2021 Q2 | 12.17 Million NZD | 0.0% |
2020 Q4 | 8.07 Million NZD | 0.0% |
2020 FY | 8.07 Million NZD | -35.64% |
2020 Q3 | 8.07 Million NZD | -37.87% |
2020 Q2 | 12.99 Million NZD | 0.0% |
2020 Q1 | 12.99 Million NZD | 3.59% |
2019 FY | 12.54 Million NZD | 3.11% |
2019 Q4 | 12.54 Million NZD | 0.0% |
2019 Q3 | 12.54 Million NZD | -2.52% |
2019 Q1 | 12.87 Million NZD | 5.78% |
2019 Q2 | 12.87 Million NZD | 0.0% |
2018 Q1 | 13.52 Million NZD | -10.11% |
2018 FY | 12.16 Million NZD | -19.11% |
2018 Q4 | 12.16 Million NZD | 0.0% |
2018 Q3 | 12.16 Million NZD | -10.02% |
2018 Q2 | 13.52 Million NZD | 0.0% |
2017 Q1 | 12.38 Million NZD | -15.02% |
2017 Q4 | 15.04 Million NZD | 0.0% |
2017 FY | 15.04 Million NZD | 3.19% |
2017 Q2 | 12.38 Million NZD | 0.0% |
2017 Q3 | 15.04 Million NZD | 21.44% |
2016 Q2 | 15.54 Million NZD | 0.0% |
2016 FY | 14.57 Million NZD | 36.93% |
2016 Q4 | 14.57 Million NZD | 0.0% |
2016 Q3 | 14.57 Million NZD | -6.22% |
2016 Q1 | 15.54 Million NZD | 46.02% |
2015 Q3 | 10.64 Million NZD | -3.46% |
2015 Q1 | 11.02 Million NZD | 0.0% |
2015 FY | 10.64 Million NZD | -7.44% |
2015 Q2 | 11.02 Million NZD | 0.0% |
2015 Q4 | 10.64 Million NZD | 0.0% |
2014 FY | 11.5 Million NZD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
4DMedical Limited | 120.01 Million AUD | 96.642% |
Adherium Limited | 9.88 Million AUD | 59.236% |
Aroa Biosurgery Limited | 101.82 Million AUD | 96.042% |
Atomo Diagnostics Limited | 11.37 Million AUD | 64.581% |
Anteris Technologies Ltd | 45.7 Million AUD | 91.181% |
Control Bionics Limited | 9.02 Million AUD | 55.353% |
CardieX Limited | 12.64 Million AUD | 68.139% |
Compumedics Limited | 40.35 Million AUD | 90.013% |
Cochlear Limited | 2.74 Billion AUD | 99.853% |
CleanSpace Holdings Limited | 26.05 Million AUD | 84.529% |
Cyclopharm Limited | 45.91 Million AUD | 91.222% |
EMVision Medical Devices Ltd | 23.97 Million AUD | 83.187% |
Nova Eye Medical Limited | 29.88 Million AUD | 86.512% |
HeraMED Limited | 2.95 Million AUD | -36.526% |
Imricor Medical Systems, Inc. | 12.17 Million AUD | 66.899% |
ImpediMed Limited | 46.98 Million AUD | 91.422% |
InhaleRx Limited | 1.57 Million AUD | -155.591% |
LBT Innovations Limited | 7.93 Million AUD | 49.182% |
Micro-X Limited | 26.89 Million AUD | 85.014% |
Neurotech International Limited | 12.21 Million AUD | 67.0% |
OncoSil Medical Limited | 6.71 Million AUD | 40.01% |
PolyNovo Limited | 109.16 Million AUD | 96.308% |
Respiri Limited | 6.19 Million AUD | 34.898% |
SomnoMed Limited | 69.8 Million AUD | 94.226% |
Universal Biosensors, Inc. | 30.12 Million AUD | 86.619% |
Uscom Limited | 5.13 Million AUD | 21.506% |
Visioneering Technologies, Inc. | 11.2 Million AUD | 64.032% |